Liquid-gas interface plasma device

Information

  • Patent Grant
  • 9028656
  • Patent Number
    9,028,656
  • Date Filed
    Wednesday, March 31, 2010
    14 years ago
  • Date Issued
    Tuesday, May 12, 2015
    9 years ago
Abstract
A method for whitening teeth is disclosed. The method includes supplying a liquid sufficient to at least partially submerge a portion of a tooth; positioning a plasma device adjacent to the submerged portion of the tooth; supplying ionizable media to the plasma device; and igniting the ionizable media at the plasma device sufficient to form a plasma effluent in the presence of the liquid at the distal portion, whereby the plasma effluent reacts with the liquid to form at least one reactive species that interacts selectively with foreign matter disposed on the tooth.
Description
BACKGROUND

1. Technical Field


The present disclosure relates to plasma devices and processes for surface processing and material removal or deposition. More particularly, the disclosure relates to an apparatus and method for generating and directing chemically reactive, plasma-generated species in a plasma device along with excited-state species (e.g., energetic photons) that are specific to the selected ingredients.


2. Background of Related Art


Electrical discharges in dense media, such as liquids and gases at or near atmospheric pressure, can, under appropriate conditions, result in plasma formation. Plasmas have the unique ability to create large amounts of chemical species, such as ions, radicals, electrons, excited-state (e.g., metastable) species, molecular fragments, photons, and the like. The plasma species may be generated in a variety of internal energy states or external kinetic energy distributions by tailoring plasma electron temperature and electron density. In addition, adjusting spatial, temporal and temperature properties of the plasma creates specific changes to the material being irradiated by the plasma species and associated photon fluxes. Plasmas are also capable of generating photons including energetic ultraviolet photons that have sufficient energy to initiate photochemical and photocatalytic reaction paths in biological and other materials that are irradiated by the plasma photons.


SUMMARY

Plasmas have broad applicability to provide alternative solutions to industrial, scientific and medical needs, especially workpiece surface processing at low temperature. Plasmas may be delivered to a workpiece, thereby affecting multiple changes in the properties of materials upon which the plasmas impinge. Plasmas have the unique ability to create large fluxes of radiation (e.g., ultraviolet), ions, photons, electrons and other excited-state (e.g., metastable) species which are suitable for performing material property changes with high spatial, material selectivity, and temporal control. Plasmas may also remove a distinct upper layer of a workpiece but have little or no effect on a separate underlayer of the workpiece or it may be used to selectively remove a particular tissue from a mixed tissue region or selectively remove a tissue with minimal effect to adjacent organs of different tissue type.


One suitable application of the unique chemical species is to drive non-equilibrium or selective chemical reactions at or within the workpiece to provide for selective removal of only certain types of materials. Such selective processes are especially sought in biological tissue processing (e.g., mixed or multi-layered tissue), which allows for cutting and removal of tissue at low temperatures with differential selectivity to underlayers and adjacent tissues. This is particularly useful for removal of biofilms, mixtures of fatty and muscle tissue, debridement of surface layers.


The plasma species are capable of modifying the chemical nature of tissue surfaces by breaking chemical bonds, substituting or replacing surface-terminating species (e.g., surface functionalization) through volatilization, gasification or dissolution of surface materials (e.g., etching). With proper techniques, material choices and conditions, one can remove one type of tissue entirely without affecting a nearby different type of tissue. Controlling plasma conditions and parameters (including S-parameters, V, I, Θ, and the like) allows for the selection of a set of specific particles, which, in turn, allows for selection of chemical pathways for material removal or modification as well as selectivity of removal of desired tissue type. The present disclosure provides for a system and method for creating plasma under a broad range of conditions including tailored geometries, various plasma feedstock media, number and location of electrodes and electrical excitation parameters (e.g., voltage, current, phase, frequency, pulse condition, etc.).


The supply of electrical energy that ignites and sustains the plasma discharge is delivered through substantially conductive electrodes that are in contact with the ionizable media and other plasma feedstocks. The present disclosure also provides for methods and apparatus that utilize specific electrode structures that improve and enhance desirable aspects of plasma operation such as higher electron temperature and higher secondary emission. In particular, the present disclosure provides for porous media for controlled release of chemical reactants.


Controlling plasma conditions and parameters allows for selection of a set of specific particles, which, in turn, allows for selection of chemical pathways for material removal or modification as well as selectivity of removal of desired tissue type. The present disclosure also provides for a system and method for generating plasmas that operate at or near atmospheric pressure. The plasmas include electrons that drive reactions at material surfaces in concert with other plasma species. Electrons delivered to the material surface can initiate a variety of processes including bond scission, which enables volatilization in subsequent reactions. The electron-driven reactions act synergistically with associated fluxes to achieve removal rates of material greater than either of the reactions acting alone.


The present disclosure provides for a system and method for treating tissue in a liquid media. In particular, the present disclosure provides for a plasma device that generates a plasma within a liquid media. The liquid media provides for higher density radicals, cooler environment and more chemical reaction sites for the plasma generated therein. This results in an increased chemical reaction rate between the plasma and liquid media than the reaction rate between atmospheric gases and the plasma. Liquids can provide 1,000 times higher concentrations of ions than gases, which results in increased chemical kinetics at similar conditions (e.g., temperature, pressure). In addition, liquids can create selective chemical dissolution on a plasma-modified surface. Once tissue is modified by a plasma, the surface terminations of the tissue are more reactive toward the compounds in the liquid than unmodified portions of the tissue. The liquid media provides for increase solubility between a plasma-treated surface and a solvent and can, therefore, be used to control desired chemical reactions. Further, the liquid media can be used to remove the heat from the plasma and the tissue surface.


The present disclosure also provides for systems and methods for whitening teeth. Hydrogen peroxide (H2O2) is commonly used as a tooth-whitening agent. H2O2 is applied directly (e.g., pure liquid form) or produced via chemical reactions from other compounds (e.g., carbamide peroxide). Various light sources are utilized to expedite the whitening reactions (e.g., flash lamps, ultraviolet light sources, etc.). These methods require relatively high volume concentration of hydrogen peroxide to be effective, at least 10% by volume concentration or more (e.g., 35% by volume). Lower concentrations (e.g., 5% to about 10%) require extended treatment time. In addition, use of high levels of hydrogen peroxide raises patient safety concerns. High concentration of hydrogen peroxide results in increased tooth sensitivity, mucosal irritation, alteration of enamel surface, damage to soft tissue (e.g., gums) as well as carcinogenic risks.


The present disclosure provides for a system and method of whitening teeth without using an external bleaching agent (e.g., external source of hydrogen peroxide). The method involves submerging the teeth in deionized water (e.g., via irrigation) and inserting a plasma generation device having a dielectrically covered electrode into the water. The plasma device generates a plasma in the water which produces relatively low concentration of hydrogen peroxide, about 0.03% by volume (several hours of plasma exposure), thereby reducing the safety risks associated with conventional hydrogen peroxide bleaching methods.


A method for whitening teeth is disclosed. The method includes supplying a liquid sufficient to at least partially submerge a portion of a tooth; positioning a plasma device adjacent to the submerged portion of the tooth; supplying ionizable media to the plasma device; and igniting the ionizable media at the plasma device sufficient to form a plasma effluent in the presence of the liquid at the distal portion, whereby the plasma effluent reacts with the liquid to form at least one reactive species that interacts selectively with foreign matter disposed on the tooth.


A method for whitening teeth is disclosed. The method includes supplying a liquid sufficient to at least partially submerge a portion of a tooth; positioning a plasma device adjacent to the submerged portion of the tooth; supplying ionizable media and at least one precursor feedstock to the plasma device; igniting the ionizable media and the at least one precursor feedstock at the plasma device sufficient to form a selectively reactive plasma effluent in the presence of the liquid at the distal portion, whereby the plasma effluent reacts with the liquid to form at least one reactive species that interacts selectively with foreign matter disposed on the tooth.


A method for whitening teeth is also contemplated by the present disclosure. The method includes supplying deionized water sufficient to at least partially submerge a portion of a tooth; positioning a plasma device adjacent to the submerged portion of the tooth; supplying ionizable media and at least one precursor feedstock to the plasma device; and igniting the ionizable media and the at least one precursor feedstock at the plasma device sufficient to form a plasma effluent in the presence of the deionized water at the distal portion, whereby the plasma effluent reacts with the deionized water to form at least one of hydroxide and hydrogen radicals that interacts selectively with foreign matter disposed on the tooth.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate exemplary embodiments of the disclosure and, together with a general description of the disclosure given above, and the detailed description of the embodiments given below, serve to explain the principles of the disclosure, wherein:



FIG. 1 is a schematic diagram of a plasma system according to the present disclosure;



FIG. 2 is a perspective, cross-sectional view of a plasma device according to the present disclosure;



FIG. 3 is a side, cross-sectional view of the plasma device of FIG. 2 according to the present disclosure;



FIG. 4 is a front, cross-sectional view of the plasma device of FIG. 2 according to the present disclosure;



FIG. 5 is a flow chart diagram of a method of plasma tissue treatment according to the present disclosure;



FIG. 6 is a flow chart diagram of another method of plasma tissue treatment according to the present disclosure;



FIG. 7 is a flow chart diagram of a further method of plasma tissue treatment according to the present disclosure;



FIGS. 8A and 8B shows photographs illustrating lesions formed on bone tissue using plasma according to the present disclosure;



FIG. 9 shows a photograph illustrating a lesion formed on bone tissue using plasma according to the present disclosure;



FIG. 10 shows a series of photographs illustrating effects of plasma on tooth whitening according to the present disclosure;



FIGS. 11A and 11B show scanning electron microscope images of a tooth whitened using plasma according to the present disclosure; and



FIG. 12 shows an emission spectra of radicals generated by plasma according to the present disclosure;



FIG. 13 shows an emission spectra of hydroxyl radicals generated by plasma in deionized water in the presence and in the absence of catalysts according to the present disclosure;



FIG. 14 shows an emission spectra of hydrogen alpha radicals generated by plasma in deionized water in the presence and in the absence of catalysts according to the present disclosure;



FIG. 15 shows an emission spectra of hydrogen beta radicals generated by plasma in deionized water in the presence and in the absence of catalysts according to the present disclosure; and



FIG. 16 shows a bar graph of absorbance of methylene blue in deionized water in the presence and in the absence of catalysts according to the present disclosure.





DETAILED DESCRIPTION

Plasmas are generated using electrical energy that is delivered as either direct current (DC) electricity or alternating current (AC) electricity at frequencies from about 0.1 hertz (Hz) to about 100 gigahertz (GHz), including radio frequency (“RF”, from about 0.1 MHz to about 100 MHz) and microwave (“MW”, from about 0.1 GHz to about 100 GHz) bands, using appropriate generators, electrodes, and antennas. Choice of excitation frequency, the workpiece, as well as the electrical circuit that is used to deliver electrical energy to the circuit affects many properties and requirements of the plasma. The performance of the plasma chemical generation, the delivery system and the design of the electrical excitation circuitry are interrelated—as the choices of operating voltage, frequency and current levels (as well as phase) effect the electron temperature and electron density. Further, choices of electrical excitation and plasma device hardware also determine how a given plasma system responds dynamically to the introduction of new ingredients to the host plasma gas or liquid media. The corresponding dynamic adjustment of the electrical drive, such as via dynamic match networks or adjustments to voltage, current, or excitation frequency may be used to maintain controlled power transfer from the electrical circuit to the plasma.


Referring initially to FIG. 1, a plasma system 10 is disclosed. The system 10 includes a plasma device 12 that is coupled to a power source 14, an ionizable media source 16 and a precursor source 18. Power source 14 includes any suitable components for delivering power or matching impedance to plasma device 12. More particularly, the power source 14 may be any radio frequency generator or other suitable power source capable of producing power to ignite the ionizable media to generate plasma. The plasma device 12 may be utilized as an electrosurgical pencil for application of plasma to tissue and the power source 14 may be an electrosurgical generator that is adapted to supply the device 12 with electrical power at a frequency from about 0.1 MHz to about 2,450 MHz, in embodiments, from about 1 MHz to about 160 MHz. In another embodiment, electrical power may be supplied at two or more different frequencies (e.g., 13.56 MHz and 60 MHz). The plasma may also be ignited by using continuous or pulsed direct current (DC) electrical energy as well as continuous or pulsed RF energy or combinations thereof.


The precursor source 18 may be a bubbler or a nebulizer configured to aerosolize precursor feedstocks prior to introduction thereof into the device 12. The precursor source 18 may also be a micro droplet or injector system capable of generating predetermined refined droplet volume of the precursor feedstock from about 1 femtoliter to about 1 milliliter in volume. The precursor source 18 may also include a microfluidic device, a piezoelectric pump, or an ultrasonic vaporizer.


The system 10 provides a flow of plasma through the device 12 to a workpiece “W” (e.g., tissue). The workpiece “W” may be any type of material or object suitable for plasma treatment. Plasma feedstocks, which include ionizable media and precursor feedstocks, are supplied by the ionizable media source 16 and the precursor source 18, respectively, to the plasma device 12. During operation, the precursor feedstock and the ionizable media are provided to the plasma device 12 where the plasma feedstocks are ignited to form plasma effluent containing ions, radicals, photons from the specific excited species and metastables that carry internal energy to drive desired chemical reactions in the workpiece “W” or at the surface thereof. The feedstocks may be mixed upstream from the ignition point or midstream thereof (e.g., at the ignition point) of the plasma effluent, as shown in FIG. 1 and described in more detail below.


The ionizable media source 16 provides ionizable feedstock to the plasma device 12. The ionizable media source 16 is coupled to the plasma device 12 and may include a storage tank and a pump (not explicitly shown). The ionizable media may be a liquid or a gas such as argon, helium, neon, krypton, xenon, radon, carbon dioxide, nitrogen, hydrogen, oxygen, etc. and their mixtures, and the like, or a liquid. These and other gases may be initially in a liquid form that is gasified during application.


The precursor source 18 provides precursor feedstock to the plasma device 12. The precursor feedstock may be either in solid, gaseous or liquid form and may be mixed with the ionizable media in any state, such as solid, liquid (e.g., particulates or droplets), gas, and the combination thereof. The precursor source 18 may include a heater, such that if the precursor feedstock is liquid, it may be heated into gaseous state prior to mixing with the ionizable media.


In one embodiment, the precursors may be any chemical species capable of forming reactive species following plasma drive dissociation, such as ions, electrons, excited-state (e.g., metastable) species, molecular fragments (e.g., radicals) and the like, when ignited by electrical energy from the power source 14 or when undergoing collisions with particles (electrons, photons, or other energy-bearing species of limited and selective chemical reactivity) formed from ionizable media 16. More specifically, the precursors may include various reactive functional groups, such as acyl halide, alcohol, aldehyde, alkane, alkene, amide, amine, butyl, carboxlic, cyanate, isocyanate, ester, ether, ethyl, halide, haloalkane, hydroxyl, ketone, methyl, nitrate, nitro, nitrile, nitrite, nitroso, peroxide, hydroperoxide, oxygen, hydrogen, nitrogen, and combination thereof. In embodiments, the chemical precursors may be water, halogenoalkanes, such as dichloromethane, tricholoromethane, carbon tetrachloride, difluoromethane, trifluoromethane, carbon tetrafluoride, and the like; peroxides, such as hydrogen peroxide, acetone peroxide, benzoyl peroxide, and the like; alcohols, such as methanol, ethanol, isopropanol, ethylene glycol, propylene glycol, alkalines such as NaOH, KOH, amines, alkyls, alkenes, and the like. Such chemical precursors may be applied in substantially pure, mixed, or soluble form.


The precursors and their functional groups may be delivered to a surface to react with the surface species (e.g., molecules) of the workpiece “W.” In other words, the functional groups may be used to modify or replace existing surface terminations of the workpiece “W.” The functional groups react readily with the surface species due to their high reactivity and the reactivity imparted thereto by the plasma. In addition, the functional groups are also reacted within the plasma volume prior to delivering the plasma volume to the workpiece.


Some functional groups generated in the plasma can be reacted in situ to synthesize materials that subsequently form a deposition upon the surface. This deposition may be used for stimulating healing, killing bacteria, and increasing hydrophilic or hydroscopic properties. In addition, deposition of certain function groups may also allow for encapsulation of the surface to achieve predetermined gas/liquid diffusion, e.g., allowing gas permeation but preventing liquid exchange, to bond or stimulate bonding of surfaces, or as a physically protective layer.


The precursor source 18 and the ionizable media source 16 may be coupled to the plasma device 12 via tubing 13a and 13b, respectively. The tubing 13a and 13b may be combined into tubing 13c to deliver a mixture of the ionizable media and the precursor feedstock to the device 12 at a proximal end thereof. This allows for the plasma feedstocks, e.g., the precursor feedstock and the ionizable gas, to be delivered to the plasma device 12 simultaneously prior to ignition of the mixture therein.


In another embodiment, the ionizable media source 16 and the precursors source 18 may be coupled to the plasma device 12 via the tubing 13a and 13b at separate connections, e.g., the first connection 31 and a second connection 29, respectively, such that the mixing of the feedstocks occurs within the plasma device 12 upstream from the ignition point. In other words, the plasma feedstocks are mixed proximally of the ignition point, which may be any point between the respective sources 16 and 18 and the plasma device 12, prior to ignition of the plasma feedstocks to create the desired mix of the plasma effluent species for each specific surface treatment on the workpiece “W.”


In a further embodiment, the plasma feedstocks may be mixed midstream, e.g., at the ignition point or downstream of the plasma effluent, directly into the plasma. More specifically, the first and second connections 31, 29 may be coupled to the device 12 at the ignition point, such that the precursor feedstocks and the ionizable media are ignited concurrently as they are mixed (FIG. 1). It is also envisioned that the ionizable media may be supplied to the device 12 proximally of the ignition point, while the precursor feedstocks are mixed therewith at the ignition point.


In a further illustrative embodiment, the ionizable media may be ignited in an unmixed state and the precursors may be mixed directly into the ignited plasma. Prior to mixing, the plasma feedstocks may be ignited individually. The plasma feedstock is supplied at a predetermined pressure to create a flow of the medium through the device 12, which aids in the reaction of the plasma feedstocks and produces a plasma effluent. The plasma according to the present disclosure is generated at or near atmospheric pressure under normal atmospheric conditions.


The system 10 also includes a liquid source 40 that may include a pump or may be a gravity-fed system. The liquid source 40 is configured to supply a liquid media 34 (FIG. 4) to the workpiece “W” by submerging or otherwise irrigating the workpiece “W.”


With reference to FIGS. 1-4, the device 12 includes an electrode 22. As shown in FIG. 2, the electrode 22 has a substantially cylindrical tubular shape having lumen 29 (FIG. 3) defined therein. The electrode 22 may be formed from a conductive material suitable for ignition of plasma such as metals and metal-ceramic composites. In one embodiment, the electrode 22 may be formed from a conductive metal including a native oxide or nitride compound disposed thereon.


The electrode 22 is coupled to the power source 14 that drives plasma generation, such that the energy from the power source 14 may be used to ignite the plasma feedstocks flowing through the device 12. More specifically, the ionizable media and the precursors flow through the device 12 through the lumen 29. When the electrode 22 is energized, the plasma feedstocks are ignited and form a plasma effluent which is emitted from the distal end of the device 12 onto the workpiece “W.”


In one embodiment, the device 12 may include an optional return electrode. The return electrode may be shaped as a ring and may be disposed distally of the electrode 22. In another embodiment, the electrode 22 may be used without a return electrode since coupling is provided through the workpiece “W.”


As shown in FIGS. 2-4, the electrode 22 includes a dielectric layer 24 that covers inner and outer surfaces 30, 32 of the electrode 22. The layer 24 may be formed from an insulative or semiconductive material deposited as a film onto the inner conductor (e.g., atomic layer deposition) or as a dielectric sleeve or layer. In one illustrative embodiment, the insulative layer 24 may be a native metal oxide. The layer 24 limits the plasma action to the distal portion of the electrode 22 and provides for the creation of a plasma effluent 31 having high energy electrons.


In addition, the layer 24 provides for capacitive coupling between the electrode 22 and the ionizable media and/or precursor feedstock. The resulting capacitive circuit element structure provides for a net negative bias potential at the surface of the electrode 22, which attracts the ions and other species from the plasma effluent. These species then bombard the layer 24 and release the electrons generating additional high energy electrons.


The layer 24 may be a native oxide, or a native nitride of the metal from which the electrode 22 is formed, or may be a deposited layer or a layer formed by ion implantation. In one illustrative embodiment, the electrode 22 is formed from an aluminum alloy and the layer 24 is aluminum oxide (Al2O3) or aluminum nitride (AlN). In another illustrative embodiment, the electrode 22 is formed from a titanium alloy and the layer 24 is titanium oxide (TiO2) or titanium nitride (TiN).


The electrode 22 and the layer 24 may also be configured as a heterogeneous system. The electrode 22 may be formed from any suitable electrode substrate material (e.g., conductive metal or a semi-conductor) and the layer 24 may be disposed thereon by various coating processes. The layer 24 may be formed on the electrode 22 by exposure to an oxidizing environment, anodization, electrochemical processing, ion implantation, or deposition (e.g., sputtering, chemical vapor deposition, atomic layer deposition, etc.).


In embodiments, the layer 24 may also be formed from suitable dielectric polymeric materials, such as polytetrafluoroethylene, polypropylene, polyethylene, fluoroethylpropylene, and combinations thereof.


The high energy electrons are generated in part by the materials of the electrode 22 and in particular by the layer 24. Materials having high secondary electron emission property, γ, in response to ion and/or photon bombardment are suitable for this task. Such materials include insulators and/or semiconductors. These materials have a relatively high γ, where γ represents the number of electrons emitted per incident bombardment particle. Thus, metals generally have a low γ (e.g., less than 0.1) while insulative and semiconductor materials, such as metallic oxides have a high γ, from about 1 to about 10 with some insulators exceeding a value of 20. Thus, the layer 24 acts as a source of secondary emitted electrons, in addition to limiting the plasma to the distal end of the electrode 22.


Secondary electron emission, γ, may be described by the formula (1):

γ=Γsecondaryion  (1)


In formula (1) γ is the secondary electron emission yield or coefficient, Γsecondary is the electron flux, and Γion is the ion flux. Secondary emission occurs due to the impacts of plasma species (ions) onto the layer 24 when the ion impact collisions have sufficient energy to induce secondary electron emission, thus generating γ-mode discharges. Generally discharges are said to be in γ-mode when electron generation occurs preferentially at electrode surfaces (i.e., γ>1) instead of in the gas (an α-mode discharge). In other words, per each ion colliding with the layer 24, a predetermined number of secondary electrons are emitted. Thus, γ may also be thought of as a ratio of the Γsecondary (e.g., the electron flux) and Γion (e.g., the ion flux).


These ion collisions with the surface of the layer 24, in turn, provide sufficient energy for secondary electron emission to generate γ discharges. The ability of coating materials such as layer 24 to generate γ discharges varies with several parameters, with the most influence due to the choice of materials having a high γ as discussed above. This property allows coatings 24 to act as a source of secondary emitted electrons or as a catalytic material to enhance selected chemical reaction paths.


Over time the layer 24 may thin or be removed during the plasma operation. In order to maintain the layer 24 to continually provide a source of secondary emitted electrons, the layer 24 may be continually replenished during the plasma operation. This may be accomplished by adding species that reformulate the layer 24 on the electrode 22. In one embodiment, the precursor source 18 may provide either oxygen or nitrogen gas to the device 12 to replenish the oxide or nitride coating.


Secondary electron emission forms a sheath layer 132 about the electrode 22. The sheath layer has a working range R1, which is representative of the thickness of energetic electron sheath layer 132 disposed about the inner circumference of electrode 22. In other words, the range R1 indicates a region with a greatly increased concentration of electrons with relatively high energies that drive reactions in the gas phase. The coating on the electrode 22 can increase or enhance working range R1 of energetic secondary electrons. In particular, varying the thickness of the coating can be used to adjust the working range R1.. A gap distance Δ shows the zone where the concentration of energetic secondary electrons is relatively lower. Coating the electrodes, as discussed above, reduces gap distance Δ. In some embodiments, distance Δ may be reduced to zero and/or working range R1 may overlap thereby creating a hollow cathode effect. Namely, the range R1 is large enough to fully envelop the inner diameter D of the lumen 29.


Formation of the sheath layer 132 may also be controlled by the supply of the ionizable media and the precursors. Ionizable media and the precursors are selected that are relatively transparent to the energetic electrons released during secondary emission from the surface of the coating. As stated above, the plasma is generated at atmospheric pressure. Due to the increased entropy at such pressure, the generated electrons undergo a multitude of collisions in a relatively short period of time and space forming the sheath layer 132.


Generation of the high energy electrons is also controlled by the supply of the ionizable media and the precursors. Ionizable media and the precursors are selected that are relatively transparent to the energetic electrons released during secondary emission from the surface of the electrode 22. As stated above, the plasma is generated at atmospheric pressure. Due to the increased entropy at such pressure, the generated electrons undergo a multitude of collisions in a relatively short period of time and space forming the high energy electrons.


The reaching distance of the high energy electrons is defined by a formula (2):

Thickness=1/  (2)


In formula (2), N is the number of scattering centers, which may be the molecules of the ionizable media, the precursors and the atmospheric gases. Thus, N defines the media density. The variable, σ, is the average particle cross-section of the scattering centers. The thickness of the high energy electrons is inversely proportional to the product of N and σ. Thus, decreasing N and σ allows for generating more high energy electrons. A lower σ may be provided by using specific ionizable media compounds with molecules having a low cross-section, such as hydrogen and helium. The variable N may be lowered by heating the ionizable media to reduce the gas density and limiting the amount of media provided to the lowest amount needed to sustain the plasma reaction.


With respect to FIG. 4, the present disclosure provides for a system and method of generating the plasma effluent 31 in a liquid media 34. The workpiece “W” is also submerged in the liquid media 34 allowing the plasma effluent 31 to perform treatment thereof. The plasma effluent 31 is formed within the lumen 29 and is restricted by the dielectric layer 24. In particular, the dielectric layer 24 includes a distal portion 36 that extends distally past a distal end 38 of the electrode 22 by a predetermined distance “l.”


The liquid media 34 may be saline, deionized water or an aqueous solution of various salts (e.g., NaCl) and/or other chemical precursors from about 1×10−4 M to about 1×10−2 M. In embodiments, dilute acids may also be added to the liquid media 34, including HCl, H2SO4 and the like having pH from about 3 to about 5. In embodiments, bases such as, NaOH, KOH, may also be added. Various reactive gases such as chloride, flouride, ozone, bromine, and the like may also be added to the liquid media 34.


In embodiments, catalysts 40 may be added to the liquid media 34 as shown in FIG. 4. In another embodiment, catalysts 40 may be embedded in the dielectric layer 24. Catalysts 40 may be added in amounts from about 1% to about 50% by volume, in embodiments from about 10% to about 40% by volume. Exemplary catalysts 40 include metal oxides such as TiO2 or any other suitable catalysts 40 that generate hydroxide radicals when mixed with water. The catalysts 40 may be in the form of nanoparticles having a volume average diameter from about 0.1 nm to about 1,000 nm, in embodiments from about 5 nm to about 500 nm. Addition of catalysts 40 reduces interface temperature between the plasma effluent 32 and the liquid media 34 since catalysts 40 aid in the generation of reactive radicals at low power.


In one embodiment, DC bias may be supplied to the electrode 22 in addition to the RF power. This allows for control over the mobility of the charged particles into the plasma effluent 31. In particular, the DC bias accelerates the charged particles allowing them to reach the workpiece “W.” The charge particles accumulate at the plasma/liquid interface 35 and modify the chemical reactions at the plasma/liquid interface 35 from an equilibrium or bulk state to a non-equilibrium state. The non-equilibrium state gives rise to a selective chemical reaction at the plasma/liquid interface 35, which aids in controlling specific chemical reactions and selective removal processes.


During use, the electrode 22 may be submerged in the liquid media 34 up to a desired depth, such that the distal portion 36 is disposed a predetermined submerged distance “d” from the workpiece “W.” The submerged distance “d” may be adjusted by simply moving the device 12 in and out of the liquid media 34. In another embodiment, the dielectric layer 34 may be slidably disposed over the electrode 22 allowing for adjustment of the distance “l” by moving the dielectric layer 34 along the electrode 22.


This configuration prevents the generation of arcing and plays an important role in controlling the chemical reaction between the plasma effluent 31 and the liquid media 34 at the plasma/liquid interface 35. Submerging of the distal portion 36 concentrates the plasma effluent 31 into discharging within the liquid media 34. The submerged distance “d” is directly proportional to the temperature of the plasma effluent 31. Thus, the deeper the electrode 22 is submerged, the hotter the plasma effluent 31 becomes. Conversely, withdrawing the electrode 22 from the liquid media 34 decreases the temperature of the plasma effluent 31. This is due to the heat removal properties of the liquid media 34, since the distance “d” directly relates to the exposure of the plasma effluent 31 to the liquid media 34, which acts as a heatsink. This relationship between the submerging distance “d” and the temperature may be used to generate particular surgical effects at the workpiece “W.” In particular, varying the temperature of the plasma effluent 31 directly effects the hemostasis effect thereof.


The liquid media 34 and the workpiece “W” may be placed within a container 23. The container 23 may be formed from a conductive material and may be coupled to a ground terminal 27 of the generator 14. In another embodiment, the ground terminal 27 may be an electrode that is placed in the vicinity of the electrode 22 within the liquid media 34.


As discussed above, the ionizable media and the precursor feedstocks are supplied through the lumen 29 and energy is supplied to the electrode 22 to ignite the mixture to form the plasma effluent 31. The ionizable media may be selected to include components (e.g., Ar, He, etc.) that assist plasma action and/or improve plasma chemical processes of breaking down feedstocks into reactive species. The plasma effluent 31 is ignited and sustained by electrical energy that is delivered through the electrode 22.


The plasma effluent 31 is injected into the liquid media 34, thereby generating additional chemical reactions between the volatized components of the ionized media and feedstocks and constituents of the liquid media 34 (e.g., water molecules, ions, etc.). This results in further dissociation (e.g., breaking down of molecular components into constituents) of feedstocks, media, etc. and dispersion thereof into the liquid media 34. More specifically, interaction between the plasma effluent 31 and the liquid media 34 allows for local in-situ generation of radicals and metastable atoms and/or molecules that react with the surface of the workpiece “W.” In addition to chemical reactions, the physical force due to the flow of the plasma effluent 31 also acts on (e.g, etches) the workpiece “W” with increased chemical reaction rates.



FIG. 5 illustrates a method of applying the plasma effluent 31 to the workpiece “W” submerged in the liquid media 34. In step 200, the liquid media 34 is supplied locally to the workpiece “W” via irrigation and other suitable techniques to submerge the workpiece “W” in the liquid media 34. In step 202, the plasma device 12 is also submerged into the liquid media 34. The submerged depth “d” and the exposure distance “l” may be adjusted to achieve a desired temperature of the plasma effluent 31 as discussed above. The layer 24 may include a marking on the outside surface thereof to indicate the maximum submersion depth of the electrode 22. In step 204, the ionizable media and precursor feedstocks are supplied to the plasma device 12 and are ignited in step 206 therein to form the plasma effluent 31 within the liquid media 34. The plasma effluent 31 interacts with the liquid media 34 to form chemically reactive species that bombard the surface of the workpiece “W.” The plasma device 12 may be maintained at the workpiece “W” for any period of time until the desired tissue effect is achieved. Certain tissue effects may be achieved in relatively short period of time (e.g., bone etching) whereas other procedures (e.g., destruction of the bone tissue) may require dwell times from about 1 minute to about 2 minutes.


The plasma device 12 may also be utilized for whitening teeth. In this embodiment, the liquid media 34 may be deionized water, carbamide peroxide, an aqueous basic solution with sodium hydroxide and other suitable bases, as well as other suitable hydroxide (OH) and hydrogen (H+) radical doners. The teeth may be submerged in the liquid media 34 (e.g., via irrigation and circulation of the deionized water through the mouth). The plasma device 12, namely, the electrode 22 is submerged into the liquid media 34 to a desired depth. The plasma device 12 may be provided with suitable chemical precursors suitable for removing foreign matter (e.g., stains, plaque, etc.) disposed on tooth enamel, such as oxygen, nitrogen dioxide, carbon dioxide and mixtures thereof. In another embodiment, the plasma device 12 may be used without chemical precursor feedstocks since deionized water provides suitable chemical feedstocks for the whitening procedure.


In a further embodiment, the liquid media 34 may also include a precursor feedstock dissolved therein. The supplied precursors feedstocks or feedstocks dissolved in the liquid media 34 may be chosen for their selectivity in reacting with the foreign matter (e.g., stains, plaque, etc.) disposed on tooth enamel. In other words, the selected precursor feedstocks have higher chemical reactivity with the foreign matter relative to the chemical reactivity with the enamel tissue. Without being limited to any particular theory, it is believed that one specific reaction illustrated by formula (3) may be responsible for the bleaching action:

H2O+e→OH+H++e  (3)


The reaction depicted by formula (3) occurs at the plasma/liquid interface 35 and is characterized by the formation of hydroxide (OH) and hydrogen (H+) radicals due to the energy supplied to the water molecules by the plasma effluent 31. In addition, other radicals may also be formed at the plasma/liquid interface 35, such as oxides and hydrides. The generated radicals bombard the build-up of foreign matter on the teeth thereby whitening the teeth. More specifically, the radicals and other plasma-generated species break the bonds of the build-up into constituent compounds, which are then dissolved in the liquid media 34.



FIG. 6 illustrates a method of applying the plasma effluent 31 to whiten teeth. In step 300, the liquid media 34, namely, deionized water, is supplied locally to the teeth via irrigation and other suitable techniques to surround the teeth in the liquid media 34. The liquid media 34 is supplied in a sufficient amount to at least partially submerge a portion of a tooth. In step 302, the plasma device 12 is also submerged into the liquid media 34. The submerged depth “d” and the exposure distance “l” may be adjusted to achieve a desired temperature of the plasma effluent 31 as discussed above. The distal portion 34 may be placed directly in contact with the teeth. In step 304, the ionizable media is supplied to the plasma device 12 and is ignited in step 306 therein to form the plasma effluent 31 within the liquid media 34. The plasma effluent 31 interacts with the liquid media 34 to form hydroxide, hydrogen, hydride and oxide radicals as well as other plasma-generated species that bombard the surface of the teeth. The plasma device 12 may be maintained at the teeth for any period of time until the desired whitening effect is achieved. Certain tissue effects may be achieved in relatively short period of time (e.g., plaque removal) whereas other procedures (e.g., stain removal) may require longer dwell times.


In one embodiment, the plasma device 12 may be used to apply hydrophobic compounds such as hexamethyldisiloxane (“HMDSO”) and CF4 to the workpiece “W” to generate a hydrophobic coating on the surface thereof. The hydrophobic compounds may be supplied to the plasma through the precursor source 18. The hydrophobic compounds are mixed with the ionizable media and are volatized within the plasma device 12 and are then deposited on the workpiece “W” by the plasma effluent 31. Hydrophobic plasma-applied coating may be suitable for preventing bacterial growth on living tissue. In embodiments, the hydrophobic coating may be applied to the teeth to minimized growth of bacteria once the foreign matter has been removed from enamel of teeth.



FIG. 7 illustrates a method of applying the plasma effluent 31 to cartilage tissue in an abrasion arthroplasty procedure. In step 400, the liquid media 34 is supplied locally to the workpiece “W” (e.g., cartilage) via irrigation and other suitable techniques to submerge the workpiece “W” in the liquid media 34. In step 402, the plasma device 12 is also submerged into the liquid media 34. The submerged distance “d” and the exposure distance “l” may be adjusted to achieve a desired temperature of the plasma effluent 31 as discussed above. In step 404, the ionizable media and precursor feedstocks are supplied to the plasma device 12 and are ignited in step 406 therein to form the plasma effluent 31 within the liquid media 34. The plasma effluent 31 interacts with the liquid media 34 to form chemically reactive species that bombard the surface of the workpiece “W.” The plasma device 12 may be maintained at the workpiece “W” for any period of time until the desired tissue effect is achieved. Certain tissue effects may be achieved in relatively short period of time (e.g., bone etching) whereas other procedures (e.g., destruction of the bone tissue) may require dwell times from about 1 minute to about 2 minutes. In step 408, the hemostasis effect of the plasma effluent 31 is monitored. Since the goal of the abrasion arthroplasty procedure is to generate as many stem cells as possible via bleeding, hemostasis must be minimized. In step 410, the submersion depth “d” is adjusted to maintain a desired degree of hemostasis or lack thereof.


EXAMPLE 1
Bone Etching


FIGS. 8A and 8B illustrate the effect of the above-discussed plasma effluent on bone tissue supplied thereto in a liquid environment. In each example, bone tissue was submerged in deionized water and NaCl was added to the water to provide chloride ions (e.g., from NaCl) as a chemical precursor for forming localized lesions. The electrode was submerged into the liquid and plasma generation was initiated and maintained for two (2) minutes. The lesion in FIG. 7A was formed using an electrode having a distal portion that is submerged to the submersion distance “d” of larger than 2 mm, whereas FIG. 7B shows the effects formed by an electrode having a distal portion submerged to the submersion distance “d” of less than 2 mm. The effects of using smaller “d” are more pronounced as illustrated in FIG. 7B, which shows charring and other tissue removal due to the hotter temperature developed at the plasma effluent. The plasma effluent produced by the device at a shallow depth results in less charring but still removes the bone tissue. Lack of charring is due to a shallow submersion depth, which lowers the heat of the plasma effluent and its hemostasis effect.



FIG. 9 shows another photo illustrating the effects of application of the plasma effluent on bone tissue. Bone tissue was submerged in deionized water and NaCl was added to the water to provide chloride ions (e.g., from NaCl) as a chemical precursor for forming localized lesions. The electrode was submerged into the liquid and plasma generation was initiated and maintained for two (2) minutes. An electrode having a distal portion submerged to the submersion distance “d” of more than 2 mm was used to form the lesion. The plasma removed the bone tissue to the marrow region, which was also removed.


EXAMPLE 2
Tooth Whitening


FIG. 10 illustrates the effectiveness of the above-discussed plasma on tooth whitening. FIG. 10 shows six photographs of a tooth taken prior to treatment and at various points in the treatment process, namely, at one, two, three, four and eight minutes. The tooth was submerged in deionized water and the electrode was brought in proximity with the tooth (e.g., submerged into the liquid). Argon gas was supplied to the plasma device and plasma generation was initiated and maintained for eight minutes. The photos illustrate the gradual progression of the treatment process and complete removal of the stain from the tooth.



FIGS. 11A and 11B illustrate enlarged photos of the tooth. FIG. 11A shows the tooth at ×170 magnification illustrating the plasma treated region and a non-treated region and FIG. 11B shows the tooth at ×750 magnification in the treated region. The plasma-treated region shows a relatively smooth surface when compared with the non-treated region. The smooth surface is indicative of undamaged tooth enamel surface structure.



FIG. 12 illustrates emission spectra of the plasma species produced by the plasma. The labeled peaks show the primary species identified in the plasma, as the hydroxide, hydrogen, oxygen and argon species. This supports the above-discussed explanation for the formula (3) being the primary vehicle of radical generation.


EXAMPLE 3
Catalysts in Liquid Media

Titanium oxide (TiO2) catalysts were added into deionized water and plasma was generated within the water medium. The effectiveness of TiO2 catalysts was measured by spectroscopy of hydroxyl (OH) and hydrogen (H) radicals, namely, H beta and H alpha radicals. As illustrated in FIGS. 13-15, which show the comparison of measured intensity for the hydroxyl, H beta and H alpha radicals were generated in deionized water and deionized water having nanoparticles of TiO2. The increased intensity is indicative of a higher concentration of the radicals, which are attributed to the addition of the catalysts.



FIG. 16 shows the absorption of methylene blue in pure deionized water and in deionized water including nanoparticles of TiO2. Methylene blue is a common indicator chemical of hydroxyl radicals since methylene blue reacts with hydroxyl radicals, which causes a change in color from blue to clear. The sample with nanoparticles had a lower absorption, indicating a higher reaction ratio with the hydroxyl radicals than the pure deionized water sample. In the pure deionized water sample, the absorption value is higher since a larger amount of methelyne blue remained unreacted due to lower production of the hydroxyl particles due to the lack of the nanoparticles of TiO2.


Although the illustrative embodiments of the present disclosure have been described herein with reference to the accompanying drawings, it is to be understood that the disclosure is not limited to those precise embodiments, and that various other changes and modifications may be effected therein by one skilled in the art without departing from the scope or spirit of the disclosure. In particular, as discussed above this allows the tailoring of the relative populations of plasma species to meet needs for the specific process desired on the workpiece surface or in the volume of the reactive plasma.

Claims
  • 1. A method for whitening teeth, comprising: supplying a liquid sufficient to at least partially submerge a portion of a tooth;positioning a plasma device adjacent to the submerged portion of the tooth, the plasma device including an electrode formed from a metal alloy and a dielectric layer covering the electrode, wherein the dielectric layer is slidably disposed over the electrode;supplying ionizable media to the plasma device;igniting the ionizable media at the plasma device sufficient to form a plasma effluent in the presence of the liquid at a distal portion of the plasma device, whereby the plasma effluent reacts with the liquid to form at least one reactive species that interacts selectively with foreign matter disposed on the tooth; andsliding the dielectric layer to adjust an exposure distance of the plasma device.
  • 2. A method according to claim 1, wherein the liquid includes at least one precursor feedstock having a higher chemical reactivity with the foreign matter than with the enamel of the tooth.
  • 3. A method according to claim 2, wherein the liquid is deionized water.
  • 4. A method according to claim 3, wherein the at least one reactive species is selected from the group consisting of hydroxide and hydrogen radicals.
  • 5. A method according to claim 1, wherein the dielectric layer includes a distal portion extending distally past a distal end of the electrode by a predetermined distance.
  • 6. A method according to claim 5, further comprising: submerging the distal portion in the liquid to a desired submersion distance.
  • 7. A method according to claim 6, further comprising: adjusting the submersion distance to regulate temperature of the plasma effluent.
  • 8. A method for whitening teeth, comprising: supplying a liquid sufficient to at least partially submerge a portion of a tooth;positioning a plasma device adjacent to the submerged portion of the tooth, the plasma device including an electrode formed from a metal alloy and a dielectric layer covering the electrode, wherein the dielectric layer is slidably disposed over the electrode;supplying ionizable media and at least one precursor feedstock to the plasma device;igniting the ionizable media and the at least one precursor feedstock at the plasma device sufficient to form a selectively reactive plasma effluent in the presence of the liquid at a distal portion of the plasma device, whereby the plasma effluent reacts with the liquid to form at least one reactive species that interacts selectively with foreign matter disposed on the tooth; andsliding the dielectric layer to adjust an exposure distance of the plasma device.
  • 9. A method according to claim 8, wherein the at least one precursor feedstock has a higher chemical reactivity with the foreign matter than with enamel of the tooth.
  • 10. A method according to claim 8, further comprising: supplying a hydrophobic compound and the ionizable media to the plasma device; andigniting the ionizable media and the hydrophobic compound at the plasma device sufficient to form the plasma effluent for depositing the hydrophobic compound on the tooth to form a hydrophobic coating thereon.
  • 11. A method according to claim 8, wherein the dielectric layer includes a distal portion extending distally past a distal end of the electrode by a predetermined distance.
  • 12. A method according to claim 11, further comprising: submerging the distal portion in the liquid to a desired submersion distance.
  • 13. A method according to claim 12, further comprising: adjusting the submersion distance to regulate temperature of the plasma effluent.
  • 14. A method for whitening teeth, comprising: supplying deionized water sufficient to at least partially submerge a portion of a tooth, the plasma device including an electrode formed from a metal alloy and a dielectric layer covering the electrode, wherein the dielectric layer is slidably disposed over the electrode;positioning a plasma device adjacent to the submerged portion of the tooth;supplying ionizable media and at least one precursor feedstock to the plasma device; andigniting the ionizable media and the at least one precursor feedstock at the plasma device sufficient to form a plasma effluent in the presence of the deionized water at a distal portion of the plasma device, whereby the plasma effluent reacts with the deionized water to form at least one of hydroxide and hydrogen radicals that interacts selectively with foreign matter disposed on the tooth; andsliding the dielectric layer to adjust an exposure distance of the plasma device.
  • 15. A method according to claim 14, wherein the dielectric layer includes a distal portion extending distally past a distal end of the electrode by a predetermined distance.
  • 16. A method according to claim 15, further comprising: submerging the distal portion in the deionized water to a desired submersion distance.
  • 17. A method according to claim 16, further comprising: adjusting the submersion distance to regulate temperature of the plasma effluent.
  • 18. A method according to claim 14, further comprising: supplying a hydrophobic compound and the ionizable media to the plasma device; and igniting the ionizable media and the hydrophobic compound at the plasma device sufficient to form the plasma effluent for depositing the hydrophobic compound on the tooth and form a hydrophobic coating thereon.
CROSS-REFERENCE TO RELATED APPLICATION

The present application claims the benefit of and priority to International Application No. PCT/US2010/029485 filed by Koo et al. on Mar. 31, 2010, which is a continuation and claims the benefit and priority to International Application No. PCT/US2009/045708 filed by Moore et al. on May 29, 2009, which claims the benefit of and priority to U.S. Provisional Application Ser. No. 61/057,667 entitled “PLASMA-BASED CHEMICAL SOURCE DEVICE AND METHOD OF USE THEREOF” filed by Moore et al. on May 30, 2008, the entire contents of all of which are incorporated by reference herein.

PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/US2010/029485 3/31/2010 WO 00 11/21/2012
Publishing Document Publishing Date Country Kind
WO2011/123125 10/6/2011 WO A
US Referenced Citations (497)
Number Name Date Kind
438257 Raquet Oct 1890 A
2213820 Maxson Sep 1940 A
2598301 Rajchman May 1952 A
3134947 Charasz May 1964 A
3434476 Shaw et al. Mar 1969 A
3671195 Bersin Jun 1972 A
3838242 Goucher Sep 1974 A
3903891 Brayshaw Sep 1975 A
3938525 Coucher Feb 1976 A
3991764 Incropera et al. Nov 1976 A
4010400 Hollister Mar 1977 A
4017707 Brown et al. Apr 1977 A
4143337 Beaulieu Mar 1979 A
4177422 Deficis et al. Dec 1979 A
4181897 Miller Jan 1980 A
4188426 Auerbach Feb 1980 A
4274919 Jensen et al. Jun 1981 A
4337415 Dürr Jun 1982 A
4577165 Uehara et al. Mar 1986 A
4629887 Bernier Dec 1986 A
4629940 Gagne et al. Dec 1986 A
4780803 Dede Garcia-Santamaria Oct 1988 A
4781175 McGreevy et al. Nov 1988 A
4818916 Morrisroe Apr 1989 A
4877999 Knapp et al. Oct 1989 A
4901719 Trenconsky et al. Feb 1990 A
4922210 Flachenecker et al. May 1990 A
4956582 Bourassa Sep 1990 A
5025373 Keyser, Jr. et al. Jun 1991 A
5041110 Fleenor Aug 1991 A
5088997 Delahuerga et al. Feb 1992 A
5098430 Fleenor Mar 1992 A
5117088 Stava May 1992 A
5124526 Muller et al. Jun 1992 A
5135604 Kumar et al. Aug 1992 A
5155547 Casper et al. Oct 1992 A
5159173 Frind et al. Oct 1992 A
5180949 Durr Jan 1993 A
5217457 Delahuerga et al. Jun 1993 A
5223457 Mintz et al. Jun 1993 A
5256138 Burek et al. Oct 1993 A
5280154 Cuomo et al. Jan 1994 A
5300068 Rosar et al. Apr 1994 A
5304279 Coultas et al. Apr 1994 A
5320621 Gordon et al. Jun 1994 A
5334834 Ito et al. Aug 1994 A
RE34780 Trenconsky et al. Nov 1994 E
5383019 Farrell et al. Jan 1995 A
5384167 Nishiwaki et al. Jan 1995 A
5401350 Patrick et al. Mar 1995 A
5449356 Walbrink et al. Sep 1995 A
5449432 Hanawa Sep 1995 A
5505729 Rau Apr 1996 A
5526138 Sato Jun 1996 A
5534231 Savas Jul 1996 A
5554172 Horner et al. Sep 1996 A
5607509 Schumacher et al. Mar 1997 A
5618382 Mintz et al. Apr 1997 A
5656186 Mourou et al. Aug 1997 A
5669904 Platt, Jr. et al. Sep 1997 A
5669907 Platt, Jr. et al. Sep 1997 A
5683366 Eggers et al. Nov 1997 A
5688357 Hanawa Nov 1997 A
5697882 Eggers et al. Dec 1997 A
5707402 Heim Jan 1998 A
5708330 Rothenbuhler et al. Jan 1998 A
5720745 Farin et al. Feb 1998 A
5733511 De Francesco Mar 1998 A
5810764 Eggers et al. Sep 1998 A
5818581 Kurosawa et al. Oct 1998 A
5841531 Gliddon Nov 1998 A
5843019 Eggers et al. Dec 1998 A
5843079 Suslov Dec 1998 A
5845488 Hancock et al. Dec 1998 A
5849136 Mintz et al. Dec 1998 A
5858477 Veerasamy et al. Jan 1999 A
5865937 Shan et al. Feb 1999 A
5866985 Coultas et al. Feb 1999 A
5892328 Shang et al. Apr 1999 A
5909086 Kim et al. Jun 1999 A
5961772 Selwyn Oct 1999 A
5977715 Li et al. Nov 1999 A
6013075 Avramenko et al. Jan 2000 A
6020794 Wilbur Feb 2000 A
6024733 Eggers et al. Feb 2000 A
6027601 Hanawa Feb 2000 A
6030667 Nakagawa et al. Feb 2000 A
6033582 Lee et al. Mar 2000 A
6036878 Collins Mar 2000 A
6046546 Porter et al. Apr 2000 A
6047700 Eggers et al. Apr 2000 A
6053172 Hovda et al. Apr 2000 A
6063079 Hovda et al. May 2000 A
6063084 Farin May 2000 A
6063937 Dlubala et al. May 2000 A
6066134 Eggers et al. May 2000 A
6086585 Hovda et al. Jul 2000 A
6099523 Kim et al. Aug 2000 A
6102046 Weinstein et al. Aug 2000 A
6105581 Eggers et al. Aug 2000 A
6109268 Thapliyal et al. Aug 2000 A
6110395 Gibson, Jr. Aug 2000 A
6113597 Eggers et al. Sep 2000 A
6132575 Pandumsopom et al. Oct 2000 A
6137237 MacLennan et al. Oct 2000 A
6142992 Cheng et al. Nov 2000 A
6149620 Baker et al. Nov 2000 A
6153852 Blutke et al. Nov 2000 A
6159208 Hovda et al. Dec 2000 A
6159531 Dang et al. Dec 2000 A
6170428 Redeker et al. Jan 2001 B1
6172130 Bellesort Jan 2001 B1
6178918 Van Os et al. Jan 2001 B1
6179836 Eggers et al. Jan 2001 B1
6182469 Campbell et al. Feb 2001 B1
6183655 Wang et al. Feb 2001 B1
6190381 Olsen et al. Feb 2001 B1
6197026 Farin et al. Mar 2001 B1
6203542 Ellsberry et al. Mar 2001 B1
6206871 Zanon et al. Mar 2001 B1
6206878 Bishop et al. Mar 2001 B1
6207924 Trassy Mar 2001 B1
6210402 Olsen et al. Apr 2001 B1
6210410 Farin et al. Apr 2001 B1
6213999 Platt, Jr. et al. Apr 2001 B1
6222186 Li et al. Apr 2001 B1
6224592 Eggers et al. May 2001 B1
6225593 Howieson et al. May 2001 B1
6228078 Eggers et al. May 2001 B1
6228082 Baker et al. May 2001 B1
6228229 Raaijmakers et al. May 2001 B1
6235020 Cheng et al. May 2001 B1
6237526 Brcka May 2001 B1
6238391 Olsen et al. May 2001 B1
6242735 Li et al. Jun 2001 B1
6248250 Hanawa et al. Jun 2001 B1
6252354 Collins et al. Jun 2001 B1
6254600 Willink et al. Jul 2001 B1
6254738 Stimson et al. Jul 2001 B1
6264650 Hovda et al. Jul 2001 B1
6264651 Underwood et al. Jul 2001 B1
6264652 Eggers et al. Jul 2001 B1
6270687 Ye et al. Aug 2001 B1
6277112 Underwood et al. Aug 2001 B1
6277251 Hwang et al. Aug 2001 B1
6283961 Underwood et al. Sep 2001 B1
6287980 Hanazaki et al. Sep 2001 B1
6291938 Jewett et al. Sep 2001 B1
6296636 Cheng et al. Oct 2001 B1
6296638 Davison et al. Oct 2001 B1
6299948 Gherardi et al. Oct 2001 B1
6309387 Eggers et al. Oct 2001 B1
6313587 MacLennan et al. Nov 2001 B1
6326584 Jewett et al. Dec 2001 B1
6326739 MacLennan et al. Dec 2001 B1
6328760 James Dec 2001 B1
6329757 Morrisroe et al. Dec 2001 B1
6333481 Augeraud et al. Dec 2001 B2
6345588 Stimson Feb 2002 B1
6346108 Fischer Feb 2002 B1
6348051 Farin et al. Feb 2002 B1
6353206 Roderick Mar 2002 B1
6355032 Hovda et al. Mar 2002 B1
6363937 Hovda et al. Apr 2002 B1
6365063 Collins et al. Apr 2002 B2
6375750 Van Os et al. Apr 2002 B1
6379351 Thapliyal et al. Apr 2002 B1
6387088 Shattuck et al. May 2002 B1
6391025 Weinstein et al. May 2002 B1
6396214 Grosse et al. May 2002 B1
6401652 Mohn et al. Jun 2002 B1
6402517 Hozumi et al. Jun 2002 B1
6409933 Holland et al. Jun 2002 B1
RE37780 Lanzani et al. Jul 2002 E
6416507 Eggers et al. Jul 2002 B1
6416508 Eggers et al. Jul 2002 B1
6416633 Spence Jul 2002 B1
6424099 Kirkpatrick et al. Jul 2002 B1
6424232 Mavretic et al. Jul 2002 B1
6432103 Ellsberry et al. Aug 2002 B1
6432260 Mahoney et al. Aug 2002 B1
6443948 Suslov Sep 2002 B1
6444084 Collins Sep 2002 B1
6445141 Kastner et al. Sep 2002 B1
6459066 Khateretal Oct 2002 B1
6461350 Underwood et al. Oct 2002 B1
6461354 Olsen et al. Oct 2002 B1
6464695 Hovda et al. Oct 2002 B2
6464889 Lee et al. Oct 2002 B1
6464891 Druz et al. Oct 2002 B1
6468270 Hovda et al. Oct 2002 B1
6468274 Alleyne et al. Oct 2002 B1
6471822 Yin et al. Oct 2002 B1
6474258 Brcka Nov 2002 B2
6475217 Platt Nov 2002 B1
6482201 Olsen et al. Nov 2002 B1
6497826 Li et al. Dec 2002 B2
6500173 Underwood et al. Dec 2002 B2
6502416 Kawasumi et al. Jan 2003 B2
6502588 Li et al. Jan 2003 B2
6507155 Barnes et al. Jan 2003 B1
6525481 Klima et al. Feb 2003 B1
6534133 Kaloyeros et al. Mar 2003 B1
6540741 Underwood et al. Apr 2003 B1
6544261 Ellsberry et al. Apr 2003 B2
6558383 Cunningham et al. May 2003 B2
6565558 Lindenmeier et al. May 2003 B1
6575968 Eggers et al. Jun 2003 B1
6579289 Schnitzler Jun 2003 B2
6579426 Van Gogh et al. Jun 2003 B1
6582423 Thapliyal et al. Jun 2003 B1
6582427 Goble et al. Jun 2003 B1
6582429 Krishnan et al. Jun 2003 B2
6589237 Woloszko et al. Jul 2003 B2
6589437 Collins Jul 2003 B1
6595990 Weinstein et al. Jul 2003 B1
6617794 Barnes et al. Sep 2003 B2
6624583 Coll et al. Sep 2003 B1
6625555 Kuan et al. Sep 2003 B2
6629974 Penny et al. Oct 2003 B2
6632193 Davison et al. Oct 2003 B1
6632220 Eggers et al. Oct 2003 B1
6642526 Hartley Nov 2003 B2
6646386 Sirkis et al. Nov 2003 B1
6652717 Hong Nov 2003 B1
6653594 Nakamura et al. Nov 2003 B2
6657594 Anderson Dec 2003 B2
6659106 Hovda et al. Dec 2003 B1
6663017 Endres et al. Dec 2003 B2
6666865 Platt Dec 2003 B2
6685803 Lazarovich et al. Feb 2004 B2
6712811 Underwood et al. Mar 2004 B2
6719754 Underwood et al. Apr 2004 B2
6719883 Stimson Apr 2004 B2
6723091 Goble et al. Apr 2004 B2
6726684 Woloszko et al. Apr 2004 B1
6740842 Johnson et al. May 2004 B2
6746447 Davison et al. Jun 2004 B2
6763836 Tasto et al. Jul 2004 B2
6770071 Woloszko et al. Aug 2004 B2
6772012 Ricart et al. Aug 2004 B2
6773431 Eggers et al. Aug 2004 B2
6774569 De Vries et al. Aug 2004 B2
6780178 Palanker et al. Aug 2004 B2
6780184 Tanrisever Aug 2004 B2
6781317 Goodman Aug 2004 B1
6787730 Coccio et al. Sep 2004 B2
6805130 Tasto et al. Oct 2004 B2
6806438 Nakano et al. Oct 2004 B2
6815633 Chen et al. Nov 2004 B1
6818140 Ding Nov 2004 B2
6832996 Woloszko et al. Dec 2004 B2
6837884 Woloszko Jan 2005 B2
6837887 Woloszko et al. Jan 2005 B2
6837888 Ciarrocca et al. Jan 2005 B2
6840937 Van Wyk Jan 2005 B2
6849191 Ono et al. Feb 2005 B2
6852112 Platt Feb 2005 B2
6855143 Davison et al. Feb 2005 B2
6855225 Su et al. Feb 2005 B1
6861377 Hirai et al. Mar 2005 B1
6867859 Powell Mar 2005 B1
6876155 Howald et al. Apr 2005 B2
6890332 Truckai et al. May 2005 B2
6896672 Eggers et al. May 2005 B1
6896674 Woloszko et al. May 2005 B1
6896775 Chistyakov May 2005 B2
6909237 Park et al. Jun 2005 B1
6911029 Platt Jun 2005 B2
6915806 Pacek et al. Jul 2005 B2
6919527 Boulos et al. Jul 2005 B2
6920883 Bessette et al. Jul 2005 B2
6921398 Carmel et al. Jul 2005 B2
6922093 Kanda Jul 2005 B2
6924455 Chen et al. Aug 2005 B1
6929640 Underwood et al. Aug 2005 B1
6949096 Davison et al. Sep 2005 B2
6949887 Kirkpatrick et al. Sep 2005 B2
6958063 Soil et al. Oct 2005 B1
6974453 Woloszko et al. Dec 2005 B2
6991631 Woloszko et al. Jan 2006 B2
7004941 Tvinnereim et al. Feb 2006 B2
7019253 Johnson et al. Mar 2006 B2
7046088 Ziegler May 2006 B2
7048733 Hartley et al. May 2006 B2
7070596 Woloszko et al. Jul 2006 B1
7084832 Pribyl Aug 2006 B2
7090672 Underwood et al. Aug 2006 B2
7096819 Chen et al. Aug 2006 B2
7100532 Pribyl Sep 2006 B2
7104986 Hovda et al. Sep 2006 B2
7115185 Gonzalez et al. Oct 2006 B1
7122035 Canady Oct 2006 B2
7122965 Goodman Oct 2006 B2
7131969 Hovda et al. Nov 2006 B1
7132620 Coelho et al. Nov 2006 B2
7132996 Evans et al. Nov 2006 B2
7150745 Stern et al. Dec 2006 B2
7157857 Brouk et al. Jan 2007 B2
7160521 Porshnev et al. Jan 2007 B2
7161112 Smith et al. Jan 2007 B2
7164484 Takahashi et al. Jan 2007 B2
7165451 Brooks et al. Jan 2007 B1
7166816 Chen et al. Jan 2007 B1
7179255 Lettice et al. Feb 2007 B2
7186234 Dahla et al. Mar 2007 B2
7189939 Lee et al. Mar 2007 B2
7189940 Kumar et al. Mar 2007 B2
7192428 Eggers et al. Mar 2007 B2
7199399 Chin-Lung et al. Apr 2007 B2
7201750 Eggers et al. Apr 2007 B1
7214280 Kumar et al. May 2007 B2
7214934 Stevenson May 2007 B2
7217268 Eggers et al. May 2007 B2
7217903 Bayer et al. May 2007 B2
7220261 Truckai et al. May 2007 B2
7227097 Kumar et al. Jun 2007 B2
7238185 Palanker et al. Jul 2007 B2
7241293 Davison Jul 2007 B2
7270658 Woloszko et al. Sep 2007 B2
7270659 Ricart et al. Sep 2007 B2
7270661 Dahla et al. Sep 2007 B2
7271363 Lee et al. Sep 2007 B2
7275344 Woodmansee, III et al. Oct 2007 B2
7276063 Davison et al. Oct 2007 B2
7282244 Schaepkens et al. Oct 2007 B2
7291804 Suslov Nov 2007 B2
7292191 Anderson Nov 2007 B2
7297143 Woloszko et al. Nov 2007 B2
7297145 Woloszko et al. Nov 2007 B2
7298091 Pickard et al. Nov 2007 B2
7309843 Kumar et al. Dec 2007 B2
7311708 McClurken Dec 2007 B2
7316682 Konesky Jan 2008 B2
7318823 Sharps et al. Jan 2008 B2
7331957 Woloszko et al. Feb 2008 B2
7353771 Millner et al. Apr 2008 B2
7355379 Kitamura et al. Apr 2008 B2
7357798 Sharps et al. Apr 2008 B2
7361175 Suslov Apr 2008 B2
7382129 Mills Jun 2008 B2
7387625 Hovda et al. Jun 2008 B2
7393351 Woloszko et al. Jul 2008 B2
7399944 DeVries et al. Jul 2008 B2
7410669 Dieckhoff et al. Aug 2008 B2
7419488 Ciarrocca et al. Sep 2008 B2
7426900 Brcka Sep 2008 B2
7429260 Underwood et al. Sep 2008 B2
7429262 Woloszko et al. Sep 2008 B2
7431857 Shannon et al. Oct 2008 B2
7435247 Woloszko et al. Oct 2008 B2
7442191 Hovda et al. Oct 2008 B2
7445619 Auge, II et al. Nov 2008 B2
7449021 Underwood et al. Nov 2008 B2
7453403 Anderson Nov 2008 B2
7458973 Ouchi Dec 2008 B2
7459899 Mattaboni et al. Dec 2008 B2
7468059 Eggers et al. Dec 2008 B2
7480299 O'Keeffe et al. Jan 2009 B2
7489206 Kotani et al. Feb 2009 B2
7491200 Underwood Feb 2009 B2
7497119 Brooks et al. Mar 2009 B2
7498000 Pekshev et al. Mar 2009 B2
7506014 Drummond Mar 2009 B2
7507236 Eggers et al. Mar 2009 B2
7510665 Shannon et al. Mar 2009 B2
7511246 Morris Mar 2009 B2
7549990 Canady Jun 2009 B2
7563261 Carmel et al. Jul 2009 B2
7566333 Van Wyk et al. Jul 2009 B2
7572255 Sartor et al. Aug 2009 B2
7578817 Canady Aug 2009 B2
7578818 Platt Aug 2009 B2
7589473 Suslov Sep 2009 B2
7601150 Farin Oct 2009 B2
7608839 Coulombe et al. Oct 2009 B2
7611509 Van Wyk Nov 2009 B2
7628787 Sartor et al. Dec 2009 B2
7632267 Dahla Dec 2009 B2
7633231 Watson Dec 2009 B2
7648503 Podhajsky Jan 2010 B2
7666478 Paulussen et al. Feb 2010 B2
7691101 Davison et al. Apr 2010 B2
7691102 Podhajsky et al. Apr 2010 B2
7708733 Sanders et al. May 2010 B2
7715889 Ito May 2010 B2
7758575 Beller Jul 2010 B2
7824398 Woloszko et al. Nov 2010 B2
7879034 Woloszko et al. Feb 2011 B2
7887891 Rius Feb 2011 B2
7892223 Geiselhart Feb 2011 B2
7892230 Woloszko Feb 2011 B2
7901403 Woloszko et al. Mar 2011 B2
7940008 Mattaboni et al. May 2011 B2
7949407 Kaplan et al. May 2011 B2
20010025177 Woloszko et al. Sep 2001 A1
20010054601 Ding Dec 2001 A1
20020014832 Moradi et al. Feb 2002 A1
20020022836 Goble et al. Feb 2002 A1
20020022838 Cunningham et al. Feb 2002 A1
20020023899 Khater et al. Feb 2002 A1
20020092826 Ding Jul 2002 A1
20020125207 Ono et al. Sep 2002 A1
20020132380 Nakano et al. Sep 2002 A1
20020148734 Bleck et al. Oct 2002 A1
20030006019 Johnson et al. Jan 2003 A1
20030008327 Ornatskaia Jan 2003 A1
20030027186 Pierce Feb 2003 A1
20030036753 Morgan et al. Feb 2003 A1
20030075522 Weichart et al. Apr 2003 A1
20030093073 Platt May 2003 A1
20030105456 Lin Jun 2003 A1
20030108683 Wu Jun 2003 A1
20030132198 Ono et al. Jul 2003 A1
20030158545 Hovda et al. Aug 2003 A1
20030208194 Hovda et al. Nov 2003 A1
20030228416 Iwamaru Dec 2003 A1
20040007985 De Vries et al. Jan 2004 A1
20040027127 Mills Feb 2004 A1
20040075375 Miyashila et al. Apr 2004 A1
20040086434 Gadgil et al. May 2004 A1
20040111219 Gulati Jun 2004 A1
20040116918 Konesky Jun 2004 A1
20040129212 Gadgil et al. Jul 2004 A1
20040138658 Farin et al. Jul 2004 A1
20040181220 Farin Sep 2004 A1
20050015001 Lec et al. Jan 2005 A1
20050017646 Boulos et al. Jan 2005 A1
20050080413 Canady Apr 2005 A1
20050103748 Yamaguchi et al. May 2005 A1
20050107786 Canady May 2005 A1
20050205212 Singh et al. Sep 2005 A1
20060004354 Suslov Jan 2006 A1
20060011465 Burke et al. Jan 2006 A1
20060017388 Stevenson Jan 2006 A1
20060036239 Canady Feb 2006 A1
20060038992 Morrisroe Feb 2006 A1
20060052771 Sartor et al. Mar 2006 A1
20060065628 Vahedi et al. Mar 2006 A1
20060084154 Jones, Jr. et al. Apr 2006 A1
20060127879 Fuccione Jun 2006 A1
20060172429 Nilsson et al. Aug 2006 A1
20060175015 Chen et al. Aug 2006 A1
20060200122 Sartor et al. Sep 2006 A1
20060224146 Lin Oct 2006 A1
20060266735 Shannon et al. Nov 2006 A1
20060278254 Jackson Dec 2006 A1
20070014752 Roy et al. Jan 2007 A1
20070021747 Suslov Jan 2007 A1
20070021748 Suslov Jan 2007 A1
20070029292 Suslov Feb 2007 A1
20070029500 Coulombe et al. Feb 2007 A1
20070039389 Brooks et al. Feb 2007 A1
20070084563 Holland Apr 2007 A1
20070087455 Hoffman Apr 2007 A1
20070149970 Schnitzler et al. Jun 2007 A1
20070163499 Finn et al. Jul 2007 A1
20070207442 Yarborough Sep 2007 A1
20070210035 Twarog et al. Sep 2007 A1
20070213704 Truckai et al. Sep 2007 A1
20070251920 Hoffman Nov 2007 A1
20070255271 Dabney et al. Nov 2007 A1
20070258329 Winey Nov 2007 A1
20070282322 Dabney et al. Dec 2007 A1
20070282323 Woloszko et al. Dec 2007 A1
20070292972 Paulussen et al. Dec 2007 A1
20080023443 Paterson et al. Jan 2008 A1
20080039832 Palanker et al. Feb 2008 A1
20080083701 Shao et al. Apr 2008 A1
20080099434 Chandrachood et al. May 2008 A1
20080099435 Grimbergen May 2008 A1
20080099436 Grimbergen May 2008 A1
20080108985 Konesky May 2008 A1
20080122252 Corke et al. May 2008 A1
20080167398 Patil et al. Jul 2008 A1
20080179290 Collins et al. Jul 2008 A1
20080185366 Suslov Aug 2008 A1
20080268172 Fukuda et al. Oct 2008 A1
20080284506 Messer Nov 2008 A1
20080292497 Vangeneugden et al. Nov 2008 A1
20080296567 Irving et al. Dec 2008 A1
20090004620 Liu et al. Jan 2009 A1
20090039789 Nikolay Feb 2009 A1
20090048594 Sartor et al. Feb 2009 A1
20090054893 Sartor et al. Feb 2009 A1
20090054896 Fridman et al. Feb 2009 A1
20090064933 Liu et al. Mar 2009 A1
20090076505 Arts Mar 2009 A1
20090216226 Davison et al. Aug 2009 A1
20090275941 Sartor et al. Nov 2009 A1
20100016856 Platt, Jr. Jan 2010 A1
20100042094 Arts Feb 2010 A1
20100069902 Sartor et al. Mar 2010 A1
20100089742 Suslov Apr 2010 A1
20100114096 Podhajsky May 2010 A1
20100130973 Choi et al. May 2010 A1
20100209293 Ikawa et al. Aug 2010 A1
Foreign Referenced Citations (28)
Number Date Country
3710489 Nov 1987 DE
4139029 Jun 1993 DE
4326037 Feb 1995 DE
9117019 Apr 1995 DE
19537897 Mar 1997 DE
9117299 Apr 2000 DE
19848784 May 2000 DE
29724247 Aug 2000 DE
19524645 Nov 2002 DE
0016542 Oct 1980 EP
0016542 Oct 1980 EP
0 495 699 Jul 1992 EP
0602764 Jun 1994 EP
0956827 Nov 1999 EP
1174901 Jan 2002 EP
1340509 Sep 1963 FR
61-159953 Jul 1986 JP
2010-242857 Oct 2010 JP
1438745 Nov 1988 SU
WO 9901887 Jan 1999 WO
WO 9936940 Jul 1999 WO
WO 0139555 May 2001 WO
WO 2004032176 Apr 2004 WO
WO 2006116252 Nov 2006 WO
WO2009041049 Apr 2009 WO
WO 2009080273 Jul 2009 WO
2009146432 Dec 2009 WO
WO 2009146439 Dec 2009 WO
Non-Patent Literature Citations (67)
Entry
Copy of extended European Search Report issued in Appl. No. 10849146.5 dated Sep. 9, 2013.
Copy of Supplementary European Search Report from Appl. No. EP 09 75 5799 mailed Aug. 31, 2012.
U.S. Appl. No. 08/383,162, filed Feb. 3, 1995, Lawrence K. Pacer.
U.S. Appl. No. 08/619,380, filed Mar. 21, 1996, Gene H. Arts.
U.S. Appl. No. 08/621,151, filed Mar. 21, 1996, Robert B. Stoddard.
U.S. Appl. No. 08/878,694, filed Jun. 19, 1997, Lawrence K Pacer.
U.S. Appl. No. 09/270,856, filed Mar. 17, 1999, Gene H. Arts.
U.S. Appl. No. 09/504,640, filed Feb. 16, 2000, James Steven Cunningham.
U.S. Appl. No. 09/666,312, filed Sep. 21, 2000, Robert C. Platt.
U.S. Appl. No. 12/791,100, filed Jun. 1, 2010, Kristin D. Johnson.
U.S. Appl. No. 12/845,842, filed Jul. 29, 2010, Kristin D. Johnson.
Hernandez et al., “A Controlled Study of the Argon Beam Coagultor for Partial Nephrectomy”; The Journal of Urology, vol. 143, May (1990) J. Urol. 143: pp. 1062-1065.
Ward et al., “A Significant New Contribution to Radical Head and Neck Surgery”; Arch Otolaryngology, Head and Neck Surg., vol. 115 pp. 921-923 (Aug. 1989).
Lieberman et al., “Capacitive Discharges”, Principles of Plasma Discharges and Materials Processing, John Wiley & Son, Inc. (2005) pp. 387-460.
Moore et al., “Confined Geometry Interactions of Downstream RF-Excited Atmospheric Plasma Wires”, IEEE Transactions on Plasma Science, 0093-3813, (2008) pp. 1-2.
Walsh et al., “Contrasting Characteristics of Pulsed and Sinusoidal Cold Atmospheric Plasma Jets”, Applied Physics Letters, 88, 171501 (2006) pp. 1-3.
Cho et al., “Coplanar ac Discharges Between Cylindrical Electrodes With a Nanoporous Alumina Dielectric: Modular Dielectric Barrier Plasma Devices”, IEEE Transactions on Plasma Science, vol. 33, No. 2, (Apr. 2005) pp. 378-379.
Xu et al., “DBD Plasma Jet in Atmospheric Pressure Argon”, IEEE Transactions on Plasma Science, vol. 36, No. 4, (Aug. 2008), pp. 1352-1353.
Alfred Grill, “Electron Cyclotron Resonance Plasmas”, Cold Plasma in Materials Fabrication, IEEE Press (1994) pp. 40-43.
Brand et al., “Electrosurgical Debulking of Ovarian Cancer: A New Technique Using the Argon Beam Coagulator”; Gynecologic Oncology 39 pp. 115-118 (1990).
Grund et al., “Endoscopic Argon Plasma . . . Flexible Endoscopy”; Endoscopic Surgery and Allied Technologies, No. 1, vol. 2, pp. 42-46 (Feb. 1994).
Waye et al., “Endoscopic Treatment Options”; Techniques in Therapeutic Endoscopy, pp. 1.7-1.15, (1987).
B.D. Cullity, “Introduction to Magnetic Materials”, University of Notre Dame; Addison-Wesley Publishing Company, Reading MA., (1972) pp. 23-28.
Brian Chapman, “Matching Networks”, Glow Discharge Processes, John Wiley & Sons Inc., NY, (1980) pp. 153-172.
Yin et al., “Miniaturization of Inductively Coupled Plasma Sources”, IEEE Transactions on Plasma Science, vol. 27, No. 5, (Oct. 1999) pp. 1516-1524.
Park et al., “Nanoporous Anodic Alumina Film on Glass: Improving Transparency by an Ion-Drift Process”, Electrochemical and Solid-State Letters, 8 (3) (2005), pp. D5-D7.
P.A. Tulle, “Off-Resonance Microwave-Created Plasmas”, Plasma Physics, Pergamon Press (1973) vol. 15, pp. 971-976.
Lieberman et al., “Ohmic Heating”, Principles of Plasma Discharges and Materials Processing, John Wiley & Son, Inc. (2005) pp. 97-98.
Lieberman et al., “Optical Actinometry”, Principles of Plasma Discharges and Materials Processing, John Wiley & Son, Inc. (2005) pp. 277-279.
Cho et al., “Ozone Production by Nanoporous Dielectric Barrier Glow Discharge in Atmospheric Pressure Air”, Applied Physics Letters, 92, 101504, (2008) pp. 1-3.
Lieberman et al., “Particle and Energy Balance in Discharges”, Principles of Plasma Discharges and Materials Processing, John Wiley & Son, Inc. (2005) pp. 329-381.
Woloszko et al., “Plasma Characteristics of Repetitively-Pulsed Electrical Discharges in Saline Solutions Used for Surgical Procedures”, IEEE Transactions of Plasma Science, vol. 30, No. 3, (Jun. 2002) pp. 1376-1383.
Stoffels et al., “Plasma Needle for In Vivo Medical Treatment: Recent Developments and Perspectives”, Plasma Sources Science and Technology 15 (2006) pp. 169-180.
Schaper et al., “Plasma Production and Vapour Layer Production at a Pulse Power Electrode in Saline Solution:”, (2008) www.escampig2008.csic.es/PosterSessions/100.
Akitsu et al., “Plasma Sterilization Using Glow Discharge at Atmospheric Pressure”, Surface & Coatings Technology 193, (2005) pp. 29-34.
Koo et al., “Room-temperature Slot Microplasma in Atmospheric Pressure Air Between Cylindrical Electrodes With a Nanoporous Alumina Dielectric”, Applied Physics Letters, 91, 041502 (2007) pp. 1-3.
Brian Chapman, “Secondary Electron Emission”, Glow Discharge Processes, John Wiley & Sons Inc., NY, (1980) pp. 82-138.
Moore et al., “Sensitive, Nonintrusive, In-Situ Measurement of Temporally and Spatially Resolved Plasma Electric Fields”, Physical Review Letters, vol. 52, No. 7, (Feb. 13, 1984) pp. 538-541.
Lieberman et al., “Sheaths”, Principles of Plasma Discharges and Materials Processing, John Wiley & Son, Inc. (2005) pp. 11-14.
Farin et al., Technology of Argon Plasma . . . Endoscopic Applications; Endoscopic Surgery and Allied Technologies, No. 1, vol. 2, pp. 71-77 (Feb. 1994).
Lieberman et al, “The Collisionless Sheath”, Principles of Plasma Discharges and Materials Processing, John Wiley & Son, Inc. (2005) pp. 167-206.
Gupta et al., “The Potential of Pulsed Underwater Streamer Discharges as a Disinfection Technique”, IEEE Transactions on Plasma Science, vol. 36, No. 4, (Aug. 2008) pp. 1621-1632.
Mark H. Mellow, “The Role of Endoscopic Laser Therapy in Gastrointestinal Neoplasms”; Advanced Therapeutic Endoscopy, pp. 17-21, (1990).
Silverstein et al., “Thermal Coagulation Therapy for Upper Gastrointestinal Bleeding”; Advanced Therapeutic Endoscopy, pp. 79-84, 1990.
Sobolewski, Mark A., “Current and Voltage Measurements in the Gaseous Electronics Conference RF Reference Cell,” J. Res. Natl. Inst. Stand. Technol., vol. 100, No. 4, pp. 341-351 (1995).
European Search Report EP 01 10 2843.8, dated May 15, 2001.
European Search Report EP 05 00 2257, dated Jun. 1, 2005.
European Search Report EP 05 01 8087, dated Oct. 17, 2005.
European Search Report EP 06 01 9572 dated Nov. 21, 2006.
European Search Report EP 07 00 4356 dated Jul. 2, 2007.
European Search Report EP 07 00 4659 dated Feb. 19, 2008.
European Search Report EP 07 00 4659—partial dated May 24, 2007.
European Search Report EP 09 00 4975 dated Sep. 11, 2009.
European Search Report EP 09 01 0519 dated Nov. 16, 2009.
European Search Report EP 09 01 0520 dated Dec. 10, 2009.
European Search Report EP 09 01 5212.5 dated Apr. 1, 2010.
European Search Report EP 09 17 1599.5 dated Mar. 16, 2010.
European Search Report EP 09 17 1600.1 dated Jan. 26, 2010.
European Search Report EP 10 174107.2 dated Nov. 5, 2010.
European Search Report EP 10 180 912.7 dated Dec. 8, 2010.
European Search Report EP 10 186524.4 dated Feb. 18, 2011.
International Search Report PCT/US98/19284, dated Jan. 14, 1999.
European Search Report EP 11168420.5 dated Jan. 5, 2012.
European Search Report EP 08015839.7 dated Dec. 19, 2008.
International Search Report and Written Opinion from Int'l Appl. No. PCT/US2009/005398 mailed Apr. 5, 2010.
International Search Report and Written Opinion from Int'l Appl. No. PCT/US2009/005389 mailed Oct. 26, 2009.
Extended European Search Report corresponding to European Application No. 09755793.8, dated Jul. 21, 2014; 8 pages.
Related Publications (1)
Number Date Country
20130059273 A1 Mar 2013 US
Provisional Applications (1)
Number Date Country
61057667 May 2008 US
Continuations (1)
Number Date Country
Parent PCT/US2009/045708 May 2009 US
Child 13637340 US